Life sciences year in review and what's ahead | DLA Piper
The use of AI and data analytics is expected to become more prevalent in compliance programs, helping to mitigaterisksrelated to the False Claims …
Read the original at DLA Piper ↗
- Topics
- Regulation & Policy
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”